Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Reducing Disparities in Late Life Depression and Metabolic Syndrome
BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome
Status: Enrolling
Updated:  1/24/2014
Cook County Health and Hospital System
mi
from
Chicago, IL
Reducing Disparities in Late Life Depression and Metabolic Syndrome
BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome
Status: Enrolling
Updated: 1/24/2014
Cook County Health and Hospital System
mi
from
Chicago, IL
Click here to add this to my saved trials
Reducing Disparities in Late Life Depression and Metabolic Syndrome
BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome
Status: Enrolling
Updated:  1/24/2014
Resurrection Medical Center
mi
from
Chicago, IL
Reducing Disparities in Late Life Depression and Metabolic Syndrome
BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome
Status: Enrolling
Updated: 1/24/2014
Resurrection Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Omega-3 Fatty Acids and Insulin Sensitivity
Dietary Omega-3 Fatty Acids as a Therapeutic Strategy in Insulin Resistant Humans
Status: Enrolling
Updated:  1/24/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Omega-3 Fatty Acids and Insulin Sensitivity
Dietary Omega-3 Fatty Acids as a Therapeutic Strategy in Insulin Resistant Humans
Status: Enrolling
Updated: 1/24/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol
Status: Enrolling
Updated:  1/24/2014
Stanford University
mi
from
Stanford, CA
Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol
Status: Enrolling
Updated: 1/24/2014
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Hypoglycemia in Prader-Willi Syndrome
Hypoglycemia in Prader-Willi Syndrome: A Prospective Study
Status: Enrolling
Updated:  2/24/2014
University of Florida
mi
from
Gainesville, FL
Hypoglycemia in Prader-Willi Syndrome
Hypoglycemia in Prader-Willi Syndrome: A Prospective Study
Status: Enrolling
Updated: 2/24/2014
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
Status: Enrolling
Updated:  2/27/2014
University of Connecticut
mi
from
Storrs, CT
The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
Status: Enrolling
Updated: 2/27/2014
University of Connecticut
mi
from
Storrs, CT
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Alabama Internal Medicine, PC
mi
from
Birmingham, AL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Alabama Internal Medicine, PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Medical Affiliated Research Center, Inc.
mi
from
Huntsville, AL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Premier Research International LLC
mi
from
Phoenix, AZ
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Premier Research International LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Baptist Health Center for Clinical Research
mi
from
Little Rock, AR
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Baptist Health Center for Clinical Research
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
San Diego Sexual Medicine
mi
from
San Diego, CA
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
San Diego Sexual Medicine
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Los Angeles Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Meridien Research
mi
from
Bradenton, FL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Meridien Research
mi
from
Bradenton, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
PAB Clinical Research
mi
from
Brandon, FL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Innovative Research of West Florida, Inc.
mi
from
Clearwater, FL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Innovative Research of West Florida, Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Clinical Research of South Florida
mi
from
Coral Gables, FL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Clinical Research of South Florida
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Clinical Research of Hollywood, PA
mi
from
Hollywood, FL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Clinical Research of Hollywood, PA
mi
from
Hollywood, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Health Awareness
mi
from
Jupiter, FL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Health Awareness
mi
from
Jupiter, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Meridien Research
mi
from
Lakeland, FL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Meridien Research
mi
from
Lakeland, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Compass Research East, LLC
mi
from
Oviedo, FL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Compass Research East, LLC
mi
from
Oviedo, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Meridien Research
mi
from
St.Petersburg, FL
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Meridien Research
mi
from
St.Petersburg, FL
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Northwest Clinical Trials
mi
from
Boise, ID
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Northwest Clinical Trials
mi
from
Boise, ID
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Centex Studies, Inc.
mi
from
Lake Charles, LA
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Centex Studies, Inc.
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Manhattan Medical Research
mi
from
New York, NY
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Manhattan Medical Research
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Sunstone Medical Research, LLC
mi
from
Medford, OR
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Sunstone Medical Research, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Urologic Consultants of SE PA
mi
from
Bala Cynwyd, PA
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Urologic Consultants of SE PA
mi
from
Bala Cynwyd, PA
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Coastal Carolina Research Center (CCRC)
mi
from
Mount Pleasant, SC
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Coastal Carolina Research Center (CCRC)
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Austin Center for Clinical Research
mi
from
Austin, TX
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Austin Center for Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Research Across America
mi
from
Dallas, TX
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Research Across America
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Protenium Clinical Research
mi
from
Hurst, TX
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Protenium Clinical Research
mi
from
Hurst, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Jean Brown Research
mi
from
Salt Lake City, UT
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Jean Brown Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated:  3/5/2014
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU, LPCN 1021) in Hypogonadal Men
Status: Enrolling
Updated: 3/5/2014
Rainier Clinical Research Center Inc.
mi
from
Renton, WA
Click here to add this to my saved trials
Leptin to Treat Lipodystrophy
Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy
Status: Enrolling
Updated:  3/14/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Leptin to Treat Lipodystrophy
Long-Term Efficacy of Leptin Replacement in Treatment of Lipodystrophy
Status: Enrolling
Updated: 3/14/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Birmingham, AL
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Huntsville, AL
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Mesa, AZ
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Phoenix, AZ
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Tucson, AZ
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Anaheim, CA
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Los Angeles, CA
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Los Gatos, CA
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Los Gatos, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Colorado Springs, CO
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Denver, CO
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Middlebury, CT
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Middlebury, CT
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Clearwater, FL
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Jacksonville, FL
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Ocala, FL
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated:  3/21/2014
Clinical Research Facility
mi
from
Orlando, FL
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
A Multicenter, Open-Label, Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
Status: Enrolling
Updated: 3/21/2014
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials